Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 11979
TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667864(US20240122941, Compound 1 | US20240122941, Compoun...)
Affinity DataIC50: 6.10nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667886(US20240122941, Compound 19)
Affinity DataIC50: 17nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667885(US20240122941, Compound 18)
Affinity DataIC50: 31nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM50506380(CHEMBL4587968 | US20240122941, Compound 15)
Affinity DataIC50: 48nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667878(US20240122941, Compound 14)
Affinity DataIC50: 70nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667873(US20240122941, Compound 5)
Affinity DataIC50: 100nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667874(US20240122941, Compound 6)
Affinity DataIC50: 160nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667882(US20240122941, Compound 16)
Affinity DataIC50: 250nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM50542060(CHEMBL4641354 | US11274090, Example 33 Isomer 2 | ...)
Affinity DataIC50: 280nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667864(US20240122941, Compound 1 | US20240122941, Compoun...)
Affinity DataIC50: 890nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667864(US20240122941, Compound 1 | US20240122941, Compoun...)
Affinity DataIC50: 1.16E+3nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent

TargetHistone acetyltransferase p300(Human)
National Cancer Center

US Patent
LigandPNGBDBM667864(US20240122941, Compound 1 | US20240122941, Compoun...)
Affinity DataIC50: 1.31E+4nMAssay Description:SensoLyte HAT (p300) Assay Kit (ANASPEC, AS-72172) was used to assess the HAT activity inhibiting capability of a HAT inhibitor. Specifically, 10 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2024
Entry Details
Go to US Patent